Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
Olaparib maintenance monotherapy in platinum-sensitive, relapsed ovarian cancer without germline BRCA mutations: OPINION Phase IIIb study design
EACR Cancer Genomics 2019 conference: from tumour evolution to personalised immunotherapy
Whole mitochondria genome mutational spectrum in occupationally exposed lead subjects
Finding driver mutations in cancer: Elucidating the role of background mutational processes
Genomic signatures predict the immunogenicity of BRCA-deficient breast cancer
Translating insights into tumor evolution to clinical practice: promises and challenges
Breast cancer brain metastases show increased levels of genomic aberration-based homologous recombination deficiency scores relative to their corresponding primary tumors
A compendium of mutational signatures of environmental agents
Passenger mutations accurately classify human tumors
Detecting the mutational signature of homologous recombination deficiency in clinical samples
decompTumor2Sig: identification of mutational signatures active in individual tumors
Discovering novel mutation signatures by latent Dirichlet allocation with variational Bayes inference
Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases
Quantum biology and human carcinogenesis
Mutation Signatures Depend on Epigenomic Contexts
Combining Mutational Signatures, Clonal Fitness, and Drug Affinity to Define Drug-Specific Resistance Mutations in Cancer
Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility
Genomic Landscape and Mutational Signatures of Deafness-Associated Genes
The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature
Mutational signature distribution varies with DNA replication timing and strand asymmetry
Mutational analysis of uterine cervical cancer that survived multiple rounds of radiotherapy
Genomics of adult and pediatric solid tumors
Pan-cancer inference of intra-tumor heterogeneity reveals associations with different forms of genomic instability
Mutational processes shape the landscape of TP53 mutations in human cancer
Targeting BER enzymes in cancer therapy
Mutational spectra and mutational signatures: Insights into cancer aetiology and mechanisms of DNA damage and repair
Dissecting aggressive B-cell lymphoma through genomic analysis--What is clinically relevant?
Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas
A functional homologous recombination assay predicts primary chemotherapy response and long-term survival in ovarian cancer patients
Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma
A site specific model and analysis of the neutral somatic mutation rate in whole-genome cancer data
Mutational signatures reveal the role of RAD52 in p53-independent p21-driven genomic instability
Whole-exome sequencing identified mutational profiles of squamous cell carcinomas of anus
PARP inhibitors for homologous recombination-deficient prostate cancer
Molecular genomic landscapes of hepatobiliary cancer
Exome-wide somatic mutation characterization of small bowel adenocarcinoma
Germline de novo mutation clusters arise during oocyte aging in genomic regions with high double-strand-break incidence
Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancer
The landscape of genomic alterations across childhood cancers
Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours
Inherited DNA-repair defects in colorectal cancer
Evolutionary history of metastatic breast cancer reveals minimal seeding from axillary lymph nodes
Whole-Exome sequencing of acquired nevi identifies mechanisms for development and maintenance of Benign Neoplasms
Loss of heterozygosity as a marker of homologous repair deficiency in multiple myeloma: a role for PARP inhibition?
Gene aberration profile of tumors of adolescent and young adult females
Heritable tumor cell division rate heterogeneity induces clonal dominance
APOBEC-mediated mutagenesis in urothelial carcinoma is associated with improved survival, mutations in DNA damage response genes, and immune response
Three molecular pathways model colorectal carcinogenesis in L ynch syndrome
Molecular analysis of PALB2-associated breast cancers
Analysis of the prevalence of microsatellite instability in prostate cancer and response to immune checkpoint blockade
Investigating Potential Bias in Patient-Reported Outcomes in Open-label Cancer Trials
Techniques and Thresholds for Quantifying Circulating Tumor Cells in Breast Cancer
Techniques and Thresholds for Quantifying Circulating Tumor Cells in Breast Cancer
Binary file (standard input) matches
